INTELLIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.98 USD | +5.88% |
|
+0.69% | -27.91% |
| Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
| Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | 2024-04-29 | |
|---|---|---|---|---|---|
| Last | 21.53 $ | 21.17 $ | 20.02 $ | 20.76 $ | 21.98 $ |
| Volume | 849 473 | 859 470 | 1 460 292 | 1 025 682 | 1 325 211 |
| Change | -1.37% | -1.67% | -5.43% | +3.70% | +5.88% |
| Opening | 21.78 | 21.56 | 20.53 | 20.11 | 21.06 |
| High | 22.85 | 21.73 | 20.66 | 20.99 | 22.4 |
| Low | 21.50 | 21.03 | 19.64 | 19.37 | 21.06 |
Performance
| 1 day | +5.61% | ||
| 1 week | +0.05% | ||
| Current month | -20.61% | ||
| 1 month | -19.76% | ||
| 3 months | -16.58% | ||
| 6 months | -8.35% | ||
| Current year | -28.37% | ||
| 1 year | -42.13% | ||
| 3 years | -72.73% | ||
| 5 years | +33.74% |
Volumes
marketsDaily volume
319 555
Estimated daily volume
1 492 234
Avg. Volume 20 sessions
1 202 870
Daily volume ratio
1.24
Avg. Volume 20 sessions USD
26 360 896.05
Record volume 1
23 193 670
Record volume 2
21 818 940
Record volume 3
8 357 691
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
2 002 065 502
Net sales (USD)
36 275 000
Number of employees
526
Sales / Employee (USD)
68 964
Free-Float
98.63 %
Free-Float capitalization (USD)
1 967 904 673
Average Daily Capital Traded
1.32%
Highs and lows
1 week
19.37
22.85
1 month
19.3727.46
Current year
19.3734.87
1 year
19.3747.48
3 years
19.37202.73
5 years
9.18202.73
10 years
9.18202.73
Indicators
Moving average 5 days
21.06
Moving average 20 days
23.69
Moving average 50 days
26.68
Moving average 100 days
27.40
Price spread / (MMA5)
-3.89%
Price spread / (MMA20)
+8.11%
Price spread / (MMA50)
+21.73%
Price spread / (MMA100)
+25.05%
STIM
RSI 9 days
18.04
RSI 14 days
24.45
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +5.56% | +0.05% | -28.37% | -42.13% | 2B | ||
| +0.63% | +1.98% | +1.96% | +24.16% | 42.75B | ||
| -1.02% | +3.20% | +47.87% | -5.49% | 41.61B | ||
| +3.51% | +6.72% | +12.10% | -16.43% | 41.34B | ||
| -0.45% | +2.14% | -12.36% | +9.96% | 26.59B | ||
| -0.19% | +2.60% | +7.98% | +56.39% | 25.49B | ||
| +2.39% | +0.54% | -23.42% | -27.39% | 18.12B | ||
| +1.44% | +6.17% | +30.33% | +93.47% | 12.24B | ||
| +1.36% | -0.52% | -2.14% | +21.69% | 11.76B | ||
| +2.29% | +1.66% | +8.22% | +2.52% | 11B | ||
| +3.43% | +5.26% | -14.33% | -16.57% | 10.07B | ||
| +1.09% | +1.86% | -6.23% | -9.01% | 9.22B | ||
| +0.12% | +3.64% | +25.00% | -15.05% | 6.65B | ||
| +8.85% | +16.24% | +4.97% | -36.57% | 6.44B | ||
| +0.88% | +0.08% | +27.13% | +52.87% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +1.87% | +3.17% | +5.25% | +6.16% | ||
| Weighted average by Cap. | +1.20% | +3.64% | +9.46% | +8.89% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
6cb3f2fa920b44d8540.MoNx_O7fje0u4MN09d1rKmWX_ZpFGxzwhSMsiBJAfqU.SNoTlb2U4a9Zrq1EqrsxbB3fifkaLW2X8XBjxSU4KtZlzROah7i6lEK6oA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 10:53:14 am | 21.83 | 100 | 266,610 |
| 10:53:14 am | 21.83 | 100 | 266,510 |
| 10:53:09 am | 21.84 | 100 | 266,410 |
| 10:53:09 am | 21.84 | 100 | 266,310 |
| 10:53:09 am | 21.84 | 100 | 266,210 |
| 10:53:09 am | 21.84 | 100 | 266,110 |
| 10:53:09 am | 21.84 | 100 | 266,010 |
| 10:53:09 am | 21.86 | 100 | 265,910 |
| 10:53:09 am | 21.86 | 100 | 265,810 |
| 10:53:05 am | 21.88 | 100 | 265,710 |
Monthly variations
Annual change
| 2024 | -31.91% | ||
| 2023 | -12.61% | ||
| 2022 | -70.49% | ||
| 2021 | +117.35% | ||
| 2020 | +270.82% | ||
| 2019 | +7.47% | ||
| 2018 | -28.98% | ||
| 2017 | +46.61% | ||
| 2016 | -40.68% |
- Stock Market
- Equities
- NTLA Stock
- Quotes Intellia Therapeutics, Inc.
